Vimarsana
Biggest News Aggregation in the World

Page 4 - Marie Utter News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Marie Utter. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Marie Utter Today - Breaking & Trending Today

ProShare Advisors LLC Purchases 1,221 Shares of PTC Therapeutics, Inc. (NASDAQ:PTCT) - Vimarsana News

ProShare Advisors LLC Purchases 1,221 Shares of PTC Therapeutics, Inc. (NASDAQ:PTCT)

Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock.

PTC Therapeutics (NASDAQ:PTCT) Posts Quarterly Earnings Results, Misses Estimates By $0.24 EPS - Vimarsana News

PTC Therapeutics (NASDAQ:PTCT) Posts Quarterly Earnings Results, Misses Estimates By $0.24 EPS

PTC Therapeutics (NASDAQ:PTCT – Get Rating) announced its quarterly earnings data on Thursday. The biopharmaceutical company reported ($1.88) earnings per share (EPS) for the quarter, missing the consensus estimate of ($1.64) by ($0.24), Briefing.com reports. The firm had revenue of $220.38 million during the quarter, compared to analyst estimates of $200.48 million. The business’s revenue […]

PTC Therapeutics, Inc. (NASDAQ:PTCT) CAO Christine Marie Utter Sells 4,692 Shares - Vimarsana News

PTC Therapeutics, Inc. (NASDAQ:PTCT) CAO Christine Marie Utter Sells 4,692 Shares

PTC Therapeutics, Inc. (NASDAQ:PTCT – Get Rating) CAO Christine Marie Utter sold 4,692 shares of the firm’s stock in a transaction that occurred on Friday, April 21st. The stock was sold at an average price of $55.06, for a total transaction of $258,341.52. Following the transaction, the chief accounting officer now directly owns 38,059 shares […]

Brokerages Set PTC Therapeutics, Inc. (NASDAQ:PTCT) PT at $52.00 - Vimarsana News

Brokerages Set PTC Therapeutics, Inc. (NASDAQ:PTCT) PT at $52.00

PTC Therapeutics, Inc. (NASDAQ:PTCT – Get Rating) has earned an average rating of “Hold” from the fifteen ratings firms that are presently covering the firm, Marketbeat Ratings reports. One analyst has rated the stock with a sell recommendation, five have issued a hold recommendation and five have assigned a buy recommendation to the company. The […]

Source: wkrb13.com
Insider Selling: PTC Therapeutics, Inc. (NASDAQ:PTCT) CAO Sells 4,688 Shares of Stock - Vimarsana News

Insider Selling: PTC Therapeutics, Inc. (NASDAQ:PTCT) CAO Sells 4,688 Shares of Stock

PTC Therapeutics, Inc. (NASDAQ:PTCT – Get Rating) CAO Christine Marie Utter sold 4,688 shares of the business’s stock in a transaction dated Wednesday, March 29th. The stock was sold at an average price of $47.79, for a total transaction of $224,039.52. Following the completion of the transaction, the chief accounting officer now directly owns 38,059 […]